pubmed-article:15940045 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15940045 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
pubmed-article:15940045 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
pubmed-article:15940045 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:15940045 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
pubmed-article:15940045 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
pubmed-article:15940045 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:15940045 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:15940045 | lifeskim:mentions | umls-concept:C1515568 | lld:lifeskim |
pubmed-article:15940045 | lifeskim:mentions | umls-concept:C1527392 | lld:lifeskim |
pubmed-article:15940045 | lifeskim:mentions | umls-concept:C0388088 | lld:lifeskim |
pubmed-article:15940045 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:15940045 | pubmed:dateCreated | 2005-6-7 | lld:pubmed |
pubmed-article:15940045 | pubmed:abstractText | FTY720 is the first of a new drug class: sphingosine-1-phosphate receptor agonist. Its effect relates to the modulation of lymphocytes trafficking from blood and peripheral tissues to lymph nodes. This is the first study to evaluate the efficacy and safety of FTY720 in de novo renal transplantation. | lld:pubmed |
pubmed-article:15940045 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15940045 | pubmed:language | eng | lld:pubmed |
pubmed-article:15940045 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15940045 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15940045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15940045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15940045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15940045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15940045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15940045 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15940045 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15940045 | pubmed:month | Jun | lld:pubmed |
pubmed-article:15940045 | pubmed:issn | 0041-1337 | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:KahanBarry... | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:NashanBjörnB | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:Vanrenterghem... | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:WeimarWillemW | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:MouradGeorges... | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:CharpentierBe... | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:MulgaonkarSha... | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:Tedesco-Silva... | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:BoiraJosep... | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:MadsenSorenS | lld:pubmed |
pubmed-article:15940045 | pubmed:author | pubmed-author:PelletPascale... | lld:pubmed |
pubmed-article:15940045 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15940045 | pubmed:day | 15 | lld:pubmed |
pubmed-article:15940045 | pubmed:volume | 79 | lld:pubmed |
pubmed-article:15940045 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15940045 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15940045 | pubmed:pagination | 1553-60 | lld:pubmed |
pubmed-article:15940045 | pubmed:dateRevised | 2008-6-5 | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:meshHeading | pubmed-meshheading:15940045... | lld:pubmed |
pubmed-article:15940045 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15940045 | pubmed:articleTitle | FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. | lld:pubmed |
pubmed-article:15940045 | pubmed:affiliation | Hospital do Rim e Hipertensao, Sao Paulo 04038-002, Brazil. heliotedesco@hrim.com.br | lld:pubmed |
pubmed-article:15940045 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15940045 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15940045 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:15940045 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:15940045 | pubmed:publicationType | Multicenter Study | lld:pubmed |
pubmed-article:15940045 | pubmed:publicationType | Corrected and Republished Article | lld:pubmed |
pubmed-article:15940045 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15940045 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15940045 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15940045 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15940045 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15940045 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15940045 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15940045 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15940045 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15940045 | lld:pubmed |